Status:
UNKNOWN
Suppressive Antibiotic Therapy for Endocarditis
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Endocarditis
Eligibility:
All Genders
18+ years
Brief Summary
Endocarditis are deadly infections, which nowadays occurs mainly among older patients with multiple comorbidities. The incidence is notably high among patients with valvular prosthetic or implantable ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Major subject (≥18 years old)
- Subject having benefited from suppressive antibiotic therapy after collegial decision in CPR Endocarditis during the period from January 1, 2016 to January 31, 2023
- Subject not opposing the reuse of their data for the purposes of this research.
- Exclusion criteria:
- Subject having expressed opposition to participating in the study
- Death or loss of sight of the patient before initiation of suppressive antibiotic therapy.
Exclusion
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06107309
Start Date
March 1 2023
End Date
March 1 2024
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France, 67091